Article

The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer

2023-06-21

Abstract excerpt

The clinicopathological parameters such as residual tumor, grade, FIGO score are often used to predict the survival of ovarian cancer patients, but the 5-year survival of high grade serous ovarian cancer (HGSOC) still remains around 30%. In recent years, a gene expression based molecular prognostic score (mPS) was developed that showed improved prognosis in several cancers including ovarian cancer. The feature ext...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 29c717f8-2008-5021-ac4d-78834e452776
DOI: 10.1101/2023.06.19.545525

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancerDOI 10.1101/2023.06.19.545525Read

The molecular prognostic score , a classifier for risk stratification of high-grade serous ovarian cancerSemantic proximity Read

A Nine-Immune-Related Gene Prognostic Signature for Predicting Outcomes in High-Grade Serous Ovarian CancerSemantic proximity Read

Development of a novel transcription factors-related prognostic signature for serous ovarian cancerSemantic proximity Read

Prognostic gene expression signature for high-grade serous ovarian cancerSemantic proximity Read

Screening of Prognostic Molecular Markers and Establishment of Prognostic Model for G-protein Coupled Receptor-Related Genes in Epithelial Ovarian Serous Cancer Based on Machine Learning MethodSemantic proximity Read

Investigating prognostic biomarkers and tumour suppressor biology in high grade serous ovarian cancerSemantic proximity Read

Prognostic and predictive value of a mRNA signature in high-grade serous ovarian carcinoma with an integrated computation analysisSemantic proximity Read

Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Ovarian CancerSemantic proximity Read

Analyzing the extracellular matrix-dominated immune landscape of high-grade serous ovarian cancer to determine prognosis and guide therapySemantic proximity Read

Prognostic signature of ovarian cancer based on 14 tumor microenvironment genesSemantic proximity Read

Development a prognostic risk model based on B cell-related immune genes in Ovarian Cancer by integrative analysis of single-cell and bulk RNA sequencing dataSemantic proximity Read

Prognostic Risk Model of Immune-Related Genes In Ovarian CancerSemantic proximity Read